COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Posted by Written by Dezan Shira & Associates Reading Time: 13 minutes

(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on December 2, 2021)

Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.

Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.

For specific updates concerning China and related business advisory, please click here.

Please refresh the page to get the latest updates.

ASEAN coronavirus updates (Live updates by country)

Brunei

Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.   

  • Brunei reported 18 new cases on December 1, taking the total to 15,111 cases amid 97 deaths.
  • Brunei saw 35 new cases on November 30, bringing the total to 15,093 cases amid 97 deaths.
  • Brunei reported 22 new cases on November 29, bringing the total to 15,058 cases amid 97 deaths.

Cambodia

Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.  

  • Cambodia saw 26 new cases and four deaths on December 1, taking the totals to 120,160 cases and 2,944 deaths.
  • Cambodia reported 22 new cases and five deaths on November 30, bringing the tallies to 120,134 cases and 2,940 deaths.
  • Cambodia recorded 25 new cases and four deaths on November 29, taking the totals to 120,112 cases and 2,935 deaths.

Indonesia

Indonesia has commenced vaccinations with just over nine million doses being given to front-line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 270 million. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population. 

  • Indonesia reported 278 new cases and 10 deaths on December 1, taking the tallies to 4,256,687 cases and 143,840 deaths.
  • Indonesia saw 297 new cases and 11 deaths on November 30, bringing the totals to 4,256,409 cases and 143,830 deaths.
  • Indonesia recorded 176 new cases and 11 deaths on November 29, taking the tallies to 4,256,112 cases and 143,819 deaths.

Laos

Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.  

  • Laos reported 1,425 new cases and eight deaths on December 1, taking the tallies to 75,163 cases and 178 deaths.
  • Laos recorded 1,291 new cases and four deaths on November 30, bringing the totals to 73,738 cases and 170 deaths.
  • Laos saw 929 new cases and seven deaths on November 29, taking the tallies to 72,447 cases and 166 deaths.

Malaysia

Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens. 

  • Malaysia saw 5,439 new cases and 49 deaths on December 1, bringing the tallies to 2,638,221 cases and 30,474 deaths.
  • Malaysia recorded 4,879 new cases and 55 deaths on November 30, taking the totals to 2,632,782 cases and 30,425 deaths.
  • Malaysia reported 4,087 new cases and 61 deaths on November 29, bringing the tallies to 2,627,903 cases and 30,370 deaths.

Myanmar

Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.   

  • Myanmar saw 423 new cases and seven deaths on December 1, taking the totals to 522,825 cases and 19,111 deaths.
  • Myanmar reported 471 new cases and seven deaths on November 30, bringing the tallies to 522,402 cases and 19,104 deaths.
  • Myanmar recorded 370 new cases and nine deaths on November 29, taking the totals to 521,931 cases and 19,097 deaths.

Philippines

The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees. 

  • The Philippines saw 500 new cases and 167 deaths on December 1, bringing the tallies to 2,833,038 cases and 48,712 deaths.
  • The Philippines reported 425 new cases and 44 deaths on November 30, taking the totals to 2,832,734 cases and 48,545 deaths.
  • The Philippines recorded 665 new cases and 141 deaths on November 29, bringing the tallies to 2,832,375 cases and 48,501 deaths.

Singapore

Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.     

  • Singapore reported 1,324 new cases and eight deaths on December 1, taking the totals to 266,049 cases and 726 deaths.
  • Singapore saw 1,239 new cases and eight deaths on November 30, bringing the tallies to 264,725 cases and 718 deaths.
  • Singapore recorded 1,103 new cases and nine deaths on November 29, taking the totals to 263,486 cases and 710 deaths.

Thailand

Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.   

  • Thailand recorded 4,886 new cases and 43 deaths on December 1, taking the totals to 2,120,758 cases and 20,812 deaths.
  • Thailand reported 4,306 new cases and 37 deaths on November 30, bringing the tallies to 2,115,872 cases and 20,769 deaths.
  • Thailand saw 4,753 new cases and 27 deaths on November 29, taking the totals to 2,111,566 cases and 20,732 deaths.

Vietnam

Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.  

Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.

  • Vietnam recorded 14,508 new cases and 196 deaths on December 1, taking the totals to 1,252,590 cases and 25,448 deaths.
  • Vietnam reported 13,972 new cases and 197 deaths on November 30, bringing the tallies to 1,238,082 cases and 25,252 deaths.
  • Vietnam saw 13,770 new cases and 173 deaths on November 29, taking the totals to 1,224,110 cases and 25,055 deaths.

Other Asian countries and Regions

Afghanistan

Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either. 

  • As of December 1, Afghanistan has 157,359 cases and 7,309 deaths.
  • Afghanistan has 157,289 cases and 7,308 deaths as of November 29.
  • As of November 29, Afghanistan has 157,260 cases and 7,308 deaths.

Bangladesh

Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.     

  • Bangladesh has 1,576,566 cases and 27,983 deaths as of December 1.
  • As of November 30, Bangladesh has 1,576,284 cases and 27,981 deaths.
  • Bangladesh has 1,576,011 cases and 27,980 deaths as of November 29.

Bahrain

Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.  

  • Bahrain has 277,721 cases and 1,394 deaths as of December 1.
  • Bahrain has 277,690 cases and 1,394 deaths as of November 30.
  • As of November 29, Bahrain has 277,628 cases and 1,394 deaths.

China

For specific updates concerning China, please click here.

For a complete overview of China’s vaccine availability please go here.

  • China reported 73 new cases on December 2, taking the total to 98,897.
  • China recorded 113 new cases on December 1, bringing the total to 98,824.
  • China saw 39 new cases on November 30, taking the total to 98,711.

East Timor

East Timor is receiving assistance from the Gavi Institute.  

  • East Timor has 19,822 cases and 122 deaths as of November 27.
  • As of November 26, East Timor has 19,821 cases and 122 deaths.

Hong Kong

Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.  

  • Hong Kong has 12,440 cases and 213 deaths as of December 1.
  • Hong Kong has 12,437 cases and 213 deaths as of November 29.
  • As of November 29, Hong Kong has 12,431 cases and 213 deaths.

India

For a complete overview of India’s vaccine availability please go here.

  • As of December 1, India has 34,606,541 cases and 469,724 deaths.
  • India has 34,596,776 cases and 469,247 deaths as of November 30.
  • Our new India-specific updates can be found here.

Iran

Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.   

  • Iran has 6,121,757 cases and 129,912 deaths as of December 1.
  • As of November 30, Iran has 6,117,445 cases and 129,830 deaths.
  • Iran has 6,113,192 cases and 129,711 deaths as of November 29.

Iraq

Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021. 

  • Iraq has 2,082,061 cases and 23,844 deaths as of December 1.
  • As of November 30, Iraq has 2,081,172 cases and 23,820 deaths.
  • Iraq has 2,080,448 cases and 23,807 deaths as of November 29.

Japan

Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021. 

  • As of December 1, Japan has 1,727,304 cases and 18,360 deaths.
  • Japan has 1,727,221 cases and 18,359 deaths as of November 30.
  • Japan has 1,727,143 cases and 18,358 deaths as of November 29.

Jordan

Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021. 

  • Jordan has 958,990 cases and 11,633 deaths as of December 1.
  • Jordan has 953,943 cases and 11,608 deaths as of November 30.
  • As of November 29, Jordan has 948,966 cases and 11,584 deaths.

Kazakhstan

Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.  

  • As of December 1, Kazakhstan has 972,292 cases and 12,703 deaths.
  • As of November 30, Kazakhstan has 971,541 cases and 12,696 deaths.
  • Kazakhstan has 970,887 cases and 12,678 deaths as of November 29.

Kuwait

All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.

  • As of December 1, Kuwait has 413,383 cases and 2,465 deaths.
  • Kuwait has 413,362 cases and 2,465 deaths as of November 30.
  • Kuwait has 413,327 cases and 2,465 deaths as of November 29.

Kyrgyzstan

Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021. 

  • As of December 1, Kyrgyzstan has 183,404 cases and 2,749 deaths.
  • Kyrgyzstan has 183,351 cases and 2,746 deaths as of November 30.
  • Kyrgyzstan has 183,285 cases and 2,743 deaths as of November 29.

Lebanon

Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.  

  • Lebanon has 672,548 cases and 8,735 deaths as of December 1.
  • As of November 30, Lebanon has 670,656 cases and 8,725 deaths.
  • Lebanon has 668,605 cases and 8,716 deaths as of November 29.

Maldives

The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.  

  • As of December 1, the Maldives has 91,750 cases and 251 deaths.
  • The Maldives has 91,650 cases and 250 deaths as of November 30.
  • The Maldives has 91,543 cases and 250 deaths as of November 29.

Mongolia

Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021. 

  • As of December 1, Mongolia has 382,082 cases and 2,005 deaths.
  • Mongolia has 381,528 cases and 2,003 deaths as of November 30.
  • Mongolia has 381,135 cases and 1,995 deaths as of November 29.

Nepal

Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.  

  • Nepal has 821,651 cases and 11,529 deaths as of December 1.
  • As of November 30, Nepal has 821,366 cases and 11,526 deaths.
  • Nepal has 821,121 cases and 11,524 deaths as of November 29.

North Korea

North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.  

  • North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.

Oman

Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).    

  • Oman has 304,572 cases and 4,113 deaths as of December 1.
  • As of November 30, Oman has 304,554 cases and 4,113 deaths.
  • As of November 25, Oman has 304,519 cases and 4,113 deaths.

Pakistan

Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021. 

  • Pakistan has 1,285,254 cases and 28,737 deaths as of December 1.
  • Pakistan has 1,284,840 cases and 28,728 deaths as of November 30.
  • As of November 29, Pakistan has 1,284,365 cases and 28,709 deaths.

Palestine

Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.   

  • As of November 30, Palestine has 430,443 cases and 4,535 deaths.
  • Palestine has 429,697 cases and 4,528 deaths as of November 28.
  • As of November 27, Palestine has 429,333 cases and 4,524 deaths.

Qatar

Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021. 

  • As of December 1, Qatar has 243,607 cases and 611 deaths.
  • Qatar has 243,447 cases and 611 deaths as of November 30.
  • Qatar has 243,290 cases and 611 deaths as of November 29.

Russia

The complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.

  • Russia has 9,669,718 cases and 276,419 deaths as of December 1.
  • As of November 30, Russia has 9,636,881 cases and 275,193 deaths.
  • Our new Russia-specific updates here.

Saudi Arabia

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021. 

  • As of December 1, Saudi Arabia has 549,786 cases and 8,837 deaths.
  • Saudi Arabia has 549,752 cases and 8,836 deaths as of November 30.
  • Saudi Arabia has 549,720 cases and 8,834 deaths as of November 29.

South Korea

South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021. 

  • As of December 2, South Korea has 457,612 cases and 3,705 deaths.
  • South Korea has 452,350 cases and 3,658 deaths as of December 1.
  • South Korea has 447,230 cases and 3,624 deaths as of November 30.

Sri Lanka

Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.    

  • Sri Lanka has 564,733 cases and 14,372 deaths as of December 1.
  • Sri Lanka has 563,989 cases and 14,346 deaths as of November 30.
  • As of November 29, Sri Lanka has 563,267 cases and 14,328 deaths.

Taiwan

Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.  

  • As of December 1, Taiwan has 16,609 cases and 848 deaths.
  • Taiwan has 16,601 cases and 848 deaths as of November 30.
  • As of November 29, Taiwan has 16,596 cases and 848 deaths.

Turkey

Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.   

  • As of December 1, Turkey has 8,818,144 cases and 77,038 deaths.
  • Turkey has 8,795,588 cases and 76,842 deaths as of November 30.
  • Turkey has 8,770,372 cases and 76,635 deaths as of November 29.

United Arab Emirates

The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates.  The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.  

  • The UAE has 742,109 cases and 2,148 deaths as of December 1.
  • As of November 30, the UAE has 742,041 cases and 2,147 deaths.
  • The UAE has 741,976 cases and 2,146 deaths as of November 29.

Uzbekistan

Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021. 

  • Uzbekistan has 193,424 cases and 1,406 deaths as of December 1.
  • Uzbekistan has 193,208 cases and 1,402 deaths as of November 30.
  • As of November 29, Uzbekistan has 193,065 cases and 1,399 deaths.

Yemen

Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.   

  • Yemen has 10,006 cases and 1,950 deaths as of December 1.
  • As of November 30, Yemen has 10,004 cases and 1,950 deaths.
  • Yemen has 9,995 cases and 1,949 deaths as of November 29.

Related Reading


About Us

ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in SingaporeHanoiHo Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at asia@dezshira.com or visit our website at www.dezshira.com.